Beyond One Day: New 24/364 Initiative Aims for Year-Round Rare Disease Focus

CHICAGO, IL – March 04, 2026 – For the more than 300 million people living with a rare disease worldwide, the challenges of under-recognition, diagnostic delays, and social isolation do not end when the calendar flips past Rare Disease Day. In a significant move to address this gap, medical marketing agency CG Life has launched 24/364, a new cultural brand platform designed to transform a single day of awareness into a year-round, sustained conversation.

The initiative aims to leverage powerful storytelling through documentary films, community engagement, and a distinct brand identity to keep the lived experiences of patients and their families in the public consciousness every day of the year. It represents a strategic shift from episodic campaigns to a continuous effort, acknowledging that the fight for recognition, research, and support is a daily reality for millions.

Moving Past Episodic Awareness

For years, the last day of February has served as a critical anchor for the rare disease community. Rare Disease Day galvanizes patients, advocates, researchers, and policymakers, creating a powerful surge of global attention. However, advocates have long noted the challenge of maintaining that momentum across the other 364 days of the year. The 24/364 platform enters this space with a clear mission: to build a persistent cultural presence for rare diseases.

This initiative joins a landscape of dedicated organizations already working tirelessly year-round. Groups like the National Organization for Rare Disorders (NORD), Global Genes, and EURORDIS have established robust, ongoing programs for policy advocacy, patient support, and research funding. These organizations form the backbone of the rare disease community, providing essential resources and driving legislative change.

Where 24/364 aims to carve its unique niche is in its focus on cultural penetration through high-quality media. By creating a dedicated storytelling platform, CG Life is betting that compelling, human-centered narratives can bridge the gap between the medical community and the general public, fostering a deeper, more intuitive understanding of what it means to live with a rare condition. The goal is not to replace existing efforts but to amplify them by embedding the cause into broader social and cultural conversations.

A Strategic Fusion of Marketing and Mission

The launch of 24/364 is more than a philanthropic gesture; it is a calculated application of core business expertise to a critical social need. CG Life is not an outside observer but a deeply embedded player in the life sciences ecosystem. As a specialized agency built to help biopharma companies commercialize therapies for rare and hard-to-treat diseases, its team is fluent in the complex science and attuned to the unique challenges of the rare disease market.

This background provides the initiative with a unique form of credibility. The agency's daily work involves translating complex scientific innovation into compelling communication strategies for healthcare professionals and patient communities. With 24/364, it is now turning that strategic lens outward, aiming to educate the public and inspire cultural change. This fusion of marketing acumen and medical mission underscores a growing trend in corporate social responsibility, where companies leverage their most valuable assets—in this case, strategic communication and brand-building—to drive meaningful impact.

“Our goal in creating 24/364 is to drive new insights and awareness into how rare diseases affect people, families, and communities and inspire change and support throughout the year,” said David Ormesher, CEO of CG Life, in the press release. “By working together, we can make rare a bigger part of everyday health conversation and culture. Through the power of film, storytelling, and community, 24/364 will keep the light on for rare.”

The Power of Storytelling: Films, Festivals, and Community

The centerpiece of the 24/364 platform is its ambitious plan to use film to humanize the rare disease experience. The initiative has enlisted leading documentary filmmakers to produce a series of intimate, day-in-the-life profiles of individuals and families. The first of these short films is slated for release in the spring of 2026 and promises to offer an unvarnished look at the resilience, challenges, and commitment that define these families' lives.

To further cultivate this narrative movement, the platform will host a multi-day film festival in San Diego in early 2027. This event will serve as a showcase for both professional and amateur filmmakers from within the rare disease community, empowering individuals to tell their own stories in their own voices. It’s a strategy designed to build a groundswell of authentic content that can be shared across digital platforms, amplifying the message far beyond a single event.

Complementing the film initiatives is the creation of a tangible brand identity. 24/364-branded merchandise will be offered, inviting supporters to become walking ambassadors for the cause. In the world of cause-related marketing, such items serve a dual purpose: they act as conversation starters and create a sense of shared identity and purpose. By wearing and sharing the 24/364 brand, supporters can signal their commitment to year-round awareness, helping to normalize the conversation around rare diseases and visibly demonstrating the strength of the community behind it.

For the millions of people navigating the often-isolating journey of a rare disease, this sustained visibility could be transformative. The prolonged diagnostic odysseys, the scarcity of treatment options, and the lack of public understanding all contribute to a heavy burden. By keeping these stories at the forefront, 24/364 hopes to not only foster empathy but also to inspire concrete action—spurring greater investment in research, encouraging more inclusive policies, and ultimately, building a world where no one feels invisible. The platform's success will be measured by its ability to keep that light shining, long after the spotlight of a single awareness day has faded.